TrialCancer science2019

Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancer.

Tadamichi Denda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.